US › Healthcare

Somalogic Inc (SLGC)

US · Healthcare · Health Information Services

$19.04-0.42%

Last close · 2026-08-04

Latest quarter · ended 2023-09-30

Revenue

$22.0M

Revenue YoY

-47.1%

Net profit

$-22.2M

Profit YoY

+32.7%

EPS

$-0.12

EPS estimate

$-0.17

Net margin

-100.5%

EPS came in at -0.12 against a street estimate of -0.17 — a beat of 29.4%.

Key statistics

Market cap

$396.2M

Forward P/E

0.0

P/B

0.80

Book value

$2.63

EPS (TTM)

$-0.69

52-week high

$20.20

52-week low

$19.06

50-day MA

$2.43

200-day MA

$2.45

Beta

1.64

Analyst view

Analysts rate Somalogic Inc a buy (2 buy, 2 hold, 0 sell out of 4) with an average price target of $3.93.

Shareholding

Insiders

2.16%

Institutions

61.71%

Largest institutional holders

Fund	Stake
BLACKSTONE ALTERNATIVE SOLUTIONS L.L.C.	0.00%
Madryn Asset Management, LP	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Somalogic Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.